ANDA 85383, held by Wockhardt. Butabarbital Sodium.
As of Nov 16, 2026, ANDA 85383 (Butabarbital Sodium), held by Wockhardt, was first approved by FDA on Feb 26, 1979, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 26, 1979 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Butabarbital Sodium30MG/5ML ยท elixir;oral | Butabarbital Sodium | Discontinued |
| Mar 6, 1992 | Supplement 20Labeling | Approved | None posted |
| Dec 6, 1989 | Supplement 19Labeling | Approved | None posted |
| Oct 10, 1989 | Supplement 18Labeling | Approved | None posted |
| Aug 20, 1987 | Supplement 15Manufacturing | Approved | None posted |
| Feb 26, 1987 | Supplement 13Manufacturing | Approved | None posted |
| Feb 26, 1987 | Supplement 14Manufacturing | Approved | None posted |
| Dec 8, 1983 | Supplement 8Manufacturing | Approved | None posted |
| Jul 29, 1982 | Supplement 6Manufacturing | Approved | None posted |
| Feb 26, 1979 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters